Published by Michele Maatouk on 22nd June 2026
(Sharecast News) - AbbVie said on Monday that it has agreed to buy clinical-stage biotechnology company Apogee Therapeutics for $10.9bn.
URL: http://www.digitallook.com/dl/news/story/36021147/...